Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.

St. Bernards Medical Center is changing the game in treating prostate cancer with its new non-invasive treatment.

On Feb. 1, Novartis Pharmaceuticals Canada Inc. announced that the Nova Scotia government is funding Pluvicto injections for ...

Wade Bogg shared a health update via X on Friday, Feb. 7, following months of cancer treatment. The former professional ...

RedHill Biopharma has begun a trial to assess the combination of opaganib and darolutamide for metastatic castrate-resistant ...

IT’S a disease that only affects old men. Wrong. You won’t die of it, you die with it. Wrong again! Prostate cancer is the most common cancer in England, overtaking breast cancer for the first ...

David James, director of patient projects and influencing at Prostate Cancer Research, has set the record straight on some of ...

The urine test “now empowers patients to collect their samples in the comfort of their homes, a significant step forward in ...

The BC Cancer Foundation is launching a fundraising campaign to support the next three years of immunotherapy research at BC ...

Prostate cancer is a significant health issue in India, with 37,000 new cases and 18,000 deaths annually. AI is ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Longtime Chicago radio star known for "Disco Demolition" is preparing for radiation treatment but says he doesn't plan to ...